ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.6998
0.00%
Brent Oil
81.965
0.00%
Bitcoin
69,170.00
0.93%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC
  6. Ayala Pharmaceuticals Inc (PK) (ADXS)

  7. Ayala Pharmaceuticals Inc (PK) (ADXS) Noticias

ADXS

Ayala Pharmaceuticals (PK) (ADXS)

Ayala Pharmaceuticals Inc (PK)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:ADXS
FechaHoraFuenteTítuloSímboloCompañía
06/03/202406:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
05/03/202415:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
05/03/202407:16Edgar (US Regulatory)Form DEFM14C - Definitive information statement relating to merger or acquisitionUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
20/02/202416:22Edgar (US Regulatory)Form PREM14C - Preliminary information statements relating to merger or acquisitionUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
14/02/202415:26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/02/202410:58Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
03/01/202415:18Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
20/11/202308:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
15/11/202315:04Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
08/11/202315:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
03/11/202310:46Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
02/11/202315:05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
29/09/202305:13Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
11/09/202311:38Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
23/05/202312:11Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
15/05/202315:11Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
07/04/202316:21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
06/04/202316:24Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
10/02/202305:08Edgar (US Regulatory)Annual Report (10-k)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
08/02/202316:20Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
30/01/202315:52Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
30/01/202305:38Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
23/01/202317:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/01/202315:06Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
13/12/202205:03Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
13/12/202205:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/12/202215:53Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
13/06/202205:02Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/05/202215:55Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
28/03/202207:57Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
 Showing the most relevant articles for your search:USOTC:ADXS

Su Consulta Reciente

NASDAQ
AAPL
Apple
COIN
BTCUSD
Bitcoin
AMEX
SPY
SPDR S&P 500
COIN
SOLUSD
Solana
NASDAQ
AMZN
Amazon.com
USOTC
RHHBY
Roche (QX)
CCOM
US30
US 30
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
MCD
McDonalds
CCOM
US500
US 500
CCOM
OILBRENT
Brent Oil
AMEX
XLF
Financial Select Sector
NASDAQ
NVDA
NVIDIA
FX
USDMXN
US Dollar vs MXN
CCOM
SILVER
SILVER
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados